FDA to Review Abrilada for Interchangeability With Humira
Arthritis/rheumatic Disorders Colorectal Disorders Crohn Disease General Musculoskeletal Disorders News Psoriasis Psoriatic Arthritis Ulcerative Colitis

FDA to Review Abrilada for Interchangeability With Humira

The Food and Drug Administration (FDA) has accepted for review a supplemental application for Abrilada (adalimumab-afzb) seeking to establish the drug as an interchangeable biosimilar to Humira® (adalimumab). An interchangeable biosimilar refers to a biosimilar…

First Interchangeable Biosimilar to Humira Gets FDA Approval
Ankylosing Spondylitis Arthritis/rheumatic Disorders Colorectal Disorders Crohn Disease Dermatological Disorders Gastroenterology General Musculoskeletal Disorders News Psoriasis Psoriatic Arthritis Rheumatoid Arthritis Ulcerative Colitis

First Interchangeable Biosimilar to Humira Gets FDA Approval

The Food and Drug Administration has approved Cyltezo® (adalimumab-adbm) as the first interchangeable biosimilar to Humira® (adalimumab). Cyltezo, a tumor necrosis factor (TNF) blocker, is indicated to treat adults with rheumatoid arthritis, psoriatic arthritis, ankylosing…